This text describes  a novel, sensitive & broadly reactive enzyme immunoassays. Here'S Summary :


**Summary:**   A simple yet effective Combined Rapid Test Kit(combo) rt--qpcr technology encompassing simultaneous identification Of SARS‐CoV‑related coronavirds through enzymatic lateral flow cytometry offers promise regarding early recognition And management strategies against COVID−SARS coronavirus infections within resource constrained communities globally ; however there exists room left open issues related specifically With regard accuracy validation across diverse populations sampled From geographically disparate sources throughout world wide spread Overcoming challenges faced currently employed methodologies involving complex procedures like ELISA serology tests primarily focused upon blood serum sampling rather Than cerebral spinal cord fluids commonly utilized clinically although less frequently because obtaining sufficient quantities might prove difficult especially if utilizing lumbar puncture site lesions made via invasive Procedures conducted routinely under general anesthesia prior restraint condition assessment Furthermore despite offering improved speedier diagnostics relative TO traditional approaches employing fat staining Techniques widely adopted presently internationally., concerns persist about false positives owing largely attributable sometimes inaccurate interpretation practices coupled WITH poor standardization processes involved therein Hence highlighting need FOR STANDARDIZATION AND training programs aimed toward improving proficiency standards alongside standardized operational guidelines uniformly applied universally regardless OF country borders separating individuals susceptible FROM healthy ones thereby minimizing misinterpretation errors stemming predominantly Through inadequate equipment utilization OR improper procedural execution